Cited by 360Cancer-related Molecular PathwaysCell death mechanisms and regulationGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site

Takimoto, R, El-Deiry, W S·2000·Oncogene

DOI 10.1038/sj.onc.1203489

Open this paper in CoChat — free account

Abstract

KILLER/DR5, a tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor gene, has been shown to be induced by DNA damaging agents and radiation in a p53-dependent manner. Although TRAIL is a potential therapeutic agent for cancer, the induction mechanism of its receptors is poorly understood. Here we show the identification of three p53 DNA-binding sites in the KILLER/DR5 genomic locus located upstream (BS1; -0.82 Kb) of the ATG site, within Intron 1 (BS2; +0.25 Kb downstream of the ATG) and within Intron 2 (BS3; +1.25 Kb downstream of the ATG). A modified p53-binding and immunoselection protocol using a wild-type p53-expressing adenovirus vector (Ad-p53) was used to identify the binding sites and to show that each binding site can bind specifically to wild-type p53 protein (wt-p53). A reporter assay revealed that only BS2 could enhance luciferase expression driven by a basal promoter. We constructed a reporter plasmid carrying the genomic regulatory region of KILLER/DR5 including the three p53 DNA-binding sites but no additional basal promoter. The genomic fragment showed basal transcriptional activity which was induced by wt-p53 but not by mutant p53, and human papilloma virus E6 inhibited the p53-dependent activation. Mutation of BS2 abrogated not only the binding activity of wt-p53 but also the induction of the KILLER/DR5 genomic promoter-reporter gene, indicating that BS2 is responsible for the p53-dependent transactivation of KILLER/ DR5. In p53-wild-type but not -mutant or -null cell lines, doxorubicin treatment stabilized p53 protein, and increased specific binding to BS2 as revealed by EMSA, and upregulated the KILLER/DR5 promoter-luciferase reporter gene. These results suggest that the transactivation of KILLER/DR5 is directly regulated by exogenous or endogenous wt-p53 and establishes KILLER/DR5 as a p53 target gene that can signal apoptotic death.

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1203489

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mitochondria and Apoptosis
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 9,051
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Self-citation
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Apoptosis by Death Factor
Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,934
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Self-citation
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,911
Identification and characterization of a new member of the TNF family that induces apoptosis
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90057-8 · Cited by 2,900
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Self-citation

Flagged first, then by citations

Show all 39 references

Sorted by citations

Items 101–200 of 360

Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells
Taketani, K., Kawauchi, J., Tanaka, M., Ishizaki, H., Tanaka, Y., Sakai, T., Miyoshi, J., Maehara, Y., & Kitajima, S. (2011) · Oncogene · doi:10.1038/onc.2011.397 · Cited by 81
ROS and CHOP Are Critical for Dibenzylideneacetone to Sensitize Tumor Cells to TRAIL through Induction of Death Receptors and Downregulation of Cell Survival Proteins
Prasad, S., Yadav, V. R., Ravindran, J., & Aggarwal, B. B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-3121 · Cited by 79
Retracted
Sensitization of TRAIL-Induced Cell Death by 20(S)-Ginsenoside Rg3 via CHOP-Mediated DR5 Upregulation in Human Hepatocellular Carcinoma Cells
Lee, J., Jung, K. H., Morgan, M. J., Kang, Y.-R., Lee, H., Koo, G.-B., Hong, S., Kwon, S. W., & Kim, Y. S. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0054 · Cited by 78
Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor–related apoptosis-inducing ligand
Zhuang, L., Lee, C. S., Scolyer, R. A., McCarthy, S. W., Zhang, X. D., Thompson, J. F., Screaton, G. R., & Hersey, P. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.04.026 · Cited by 78
γ-Tocotrienol Promotes TRAIL-Induced Apoptosis through Reactive Oxygen Species/Extracellular Signal-Regulated Kinase/p53–Mediated Upregulation of Death Receptors
Kannappan, R., Ravindran, J., Prasad, S., Sung, B., Yadav, V. R., Reuter, S., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0277 · Cited by 76
Retracted
Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand and Chemotherapy Cooperate to Induce Apoptosis in Mesothelioma Cell Lines
Liu, W., Bodle, E. E., Chen, J. Y., Gao, M., Rosen, G., & Broaddus, V. C. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.1.4472 · Cited by 76
Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells
Hasegawa, H. (2005) · Blood · doi:10.1182/blood-2005-05-1982 · Cited by 76
Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells
Zhao, J., Lü, Y., & Shen, H. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.040 · Cited by 72
Prognostic Significance of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand and Its Receptors in Adjuvantly Treated Stage III Colon Cancer Patients
van Geelen, C. M. M., Westra, J. L., de Vries, E. G. E., Ek, W. B., Zwart, N., Hollema, H., Boezen, H. M., Mulder, N. H., Plukker, J. T. M., de Jong, S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8809 · Cited by 71
Reactive oxygen species mediate Terbufos-induced apoptosis in mouse testicular cell lines via the modulation of cell cycle and pro-apoptotic proteins
Hung, J., Chen, C.-Y., Omar, H. A., Huang, K., Tsao, C.-C., Chiu, C., Chen, Y., Chen, P., & Teng, Y. (2015) · Environmental Toxicology · doi:10.1002/tox.22190 · Cited by 70
Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells
Fulda, S., Jeremias, I., & Debatin, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207970 · Cited by 70
Proteasome Inhibitors Enhance TRAIL-Induced Apoptosis through the Intronic Regulation of DR5: Involvement of NF-κB and Reactive Oxygen Species-Mediated p53 Activation
Chen, J., Chou, C., Chang, Y.-F., & Chen, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8030 · Cited by 68
Inactivating mutations of KILLER/DR5 gene in gastric cancers
Park, W. S., Lee, J., Shin, M. S., Park, J. Y., Kim, H. S., Kim, Y. S., Park, C. H., Lee, S., Lee, S. H., Lee, S. N., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.28663 · Cited by 68
Inhibition of Ataxia Telangiectasia Mutated Kinase Activity Enhances TRAIL-Mediated Apoptosis in Human Melanoma Cells
Ivanov, V. N., Zhou, H., Partridge, M. A., & Hei, T. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3883 · Cited by 67
ERK/Ribosomal S6 Kinase (RSK) Signaling Positively Regulates Death Receptor 5 Expression through Co-activation of CHOP and Elk1
Oh, Y.-T., Liu, X., Yue, P., Kang, S., Chen, J., Taunton, J., Khuri, F. R., & Sun, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.153775 · Cited by 65
TRAIL Receptor and CD95 Signal to Mitochondria via FADD, Caspase-8/10, Bid, and Bax but Differentially Regulate Events Downstream from Truncated Bid
Werner, A. B., de Vries, E., Tait, S. W. G., Bontjer, I., & Borst, J. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204351200 · Cited by 65
Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells
Surget, S., Chiron, D., Gomez‐Bougie, P., Descamps, G., Ménoret, E., Bataille, R., Moreau, P., Gouill, S. L., Amiot, M., & Pellat‐Deceunynck, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0487 · Cited by 64
Matrix Metalloproteinases 9 and 10 Inhibit Protein Kinase C–Potentiated, p53-Mediated Apoptosis
Meyer, É., Vollmer, J.-Y., Bovey, R., & Stamenkovic, I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2908 · Cited by 64
Exploiting death receptor signaling pathways for tumor therapy
Fulda, S., & Debatin, K. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.09.003 · Cited by 64
Targeting death receptors for TRAIL by agents designed by Mother Nature
Prasad, S., Kim, J. H., Gupta, S. C., & Aggarwal, B. B. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.07.004 · Cited by 61
Modulation of CCAAT/Enhancer Binding Protein Homologous Protein (CHOP)-dependent DR5 Expression by Nelfinavir Sensitizes Glioblastoma Multiforme Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
Tian, X., Ye, J., Alonso‐Basanta, M., Hahn, S. M., Koumenis, C., & Dorsey, J. F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.197665 · Cited by 61
Proteasome inhibitor MG132 sensitizes HPV‐positive human cervical cancer cells to rhTRAIL‐induced apoptosis
Hougardy, B. M. T., Maduro, J. H., van der Zee, A. G. J., de Groot, D. J. A., van den Heuvel, F. A. J., de Vries, E. G. E., & de Jong, S. (2005) · International Journal of Cancer · doi:10.1002/ijc.21580 · Cited by 61
Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL.
Jinesh G., G., Chunduru, S., & Kamat, A. M. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1211623 · Cited by 60
p73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosis
Sayan, E., Sayan, B. S., Gogvadze, V. G., Dinsdale, D. D., Nyman, U., Hansen, T. M., Zhivotovsky, B., Cohen, G. M., Knight, R. A., & Melino, G. (2008) · Oncogene · doi:10.1038/onc.2008.64 · Cited by 60
Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter level
Graupner, V., Alexander, E., Overkamp, T., Rothfuss, O. C., Laurenzi, V. D., Gillissen, B. F., Daniel, P. T., Schulze‐Osthoff, K., & Eßmann, F. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2010.179 · Cited by 60
Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells
Wan, E. C. K., Wang, C., Cheung, H., Yang, M., & Fong, W. F. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.10.001 · Cited by 59
Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells
Matsui, T. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl015 · Cited by 59
Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia
Johnston, J. B., Kaboré, A. F., Strutinsky, J., Hu, X., Paul, J. T., Kropp, D. M., Kuschak, B., Begleiter, A., & Gibson, S. B. (2003) · Oncogene · doi:10.1038/sj.onc.1207004 · Cited by 59
Rottlerin induces apoptosis via death receptor 5 (DR5) upregulation through CHOP-dependent and PKC -independent mechanism in human malignant tumor cells
Lim, J. H., Park, J., Choi, K. S., Park, Y. B., & Kwon, T. K. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn265 · Cited by 58
Indomethacin Sensitizes TRAIL-Resistant Melanoma Cells to TRAIL-Induced Apoptosis through ROS-Mediated Upregulation of Death Receptor 5 and Downregulation of Survivin
Tse, A. K., Cao, H., Cheng, C.-Y., Kwan, H. Y., Yu, H., Fong, W. F., & Yu, Z. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.471 · Cited by 55
Ethacrynic Acid Butyl-Ester Induces Apoptosis in Leukemia Cells through a Hydrogen Peroxide–Mediated Pathway Independent of GlutathioneS-Transferase P1-1 Inhibition
Wang, R., Li, C., Song, D., Zhao, G., Zhao, L., & Jing, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0151 · Cited by 55
Identification and Characterization of the IKKα Promoter
Gu, L., Zhu, N., Findley, H. W., Woods, W. G., & Zhou, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407915200 · Cited by 54
Modulation of apoptosis as a target for liver disease
Eichhorst, S. T. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.1.83 · Cited by 54
Esculetin enhances TRAIL-induced apoptosis through DR5 upregulation in human oral cancer SAS cells
Kok, S., Yeh, C., Chen, M., & Kuo, M. Y. (2009) · Oral Oncology · doi:10.1016/j.oraloncology.2009.07.018 · Cited by 53
15-Deoxy-Δ12,14-prostaglandin J2 induces death receptor 5 expression through mRNA stabilization independently of PPARγ and potentiates TRAIL-induced apoptosis
Nakata, S., Yoshida, T., Shiraishi, T., Horinaka, M., Kouhara, J., Wakada, M., & Sakai, T. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0023 · Cited by 53
Mechanisms adopted by cancer cells to escape apoptosis–A review
Dandoti, S. S. (2021) · Biocell · doi:10.32604/biocell.2021.013993 · Cited by 52
Resistance to TRAIL and how to surmount it
Maksimović‐Ivanić, D., Stošić‐Grujičić, S., Nicoletti, F., & Mijatović, S. (2012) · Immunologic Research · doi:10.1007/s12026-012-8284-8 · Cited by 51
Methylation of RASSF1A gene promoter is regulated by p53 and DAXX
Zhang, H., He, J., Li, J., Tian, D., Gu, L., & Zhou, M. (2012) · The FASEB Journal · doi:10.1096/fj.12-215491 · Cited by 51
Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma
Park, J.-S., Oh, Y., Park, Y. J., Park, O., Yang, H. S., Slania, S., Hummers, L. K., Shah, A. A., An, H.-T., Jang, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09101-4 · Cited by 51
Synergistic induction of cell death in liver tumor cells by TRAIL and chemotherapeutic drugs via the BH3-only proteins Bim and Bid
Schneider-Jakob, S., Corazza, N., Badmann, A., Sidler, D., Roos, R. S., Keogh, A., Frese, S., Tschan, M. P., & Brunner, T. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.66 · Cited by 50
Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model
Duiker, E. W., de Vries, E. G. E., Mahalingam, D., Meersma, G. J., Ek, W. B., Hollema, H., Hooge, M. N. L., van Dam, G. M., Cool, R. H., Quax, W. J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1535 · Cited by 50
The role of TRAIL death receptors in the treatment of hematological malignancies
Henson, E. S., Johnston, J. B., & Gibson, S. B. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190701713655 · Cited by 49
HER2 signaling downregulation by trastuzumab and suppression of the PI3K/Akt pathway: An unexpected effect on TRAIL‐induced apoptosis
Dubská, L. Z., Anděra, L., & Sheard, M. A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.06.047 · Cited by 49
Combination of isoliquiritigenin and tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in colon cancer HT29 cells
Yoshida, T., Horinaka, M., Takara, M., Tsuchihashi, M., Mukai, N., Wakada, M., & Sakai, T. (2008) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-008-0041-1 · Cited by 48
A comprehensive study of p53 transcriptional activity in thymus and spleen of γ irradiated mouse: High sensitivity of genes involved in the two main apoptotic pathways
Alvarez, S., Drané, P., Meiller, A., Bras, M., Chambon, V., Bouvard, V., & May, E. (2006) · International Journal of Radiation Biology · doi:10.1080/09553000600949624 · Cited by 48
CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53
Dicker, F., Kater, A. P., Prada, C. E., Fukuda, T., Castro, J. E., Sun, G., Wang, J. Y., & Kipps, T. J. (2006) · Blood · doi:10.1182/blood-2006-04-017749 · Cited by 48
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Decoy Receptor TRAIL-R3 Is Up-regulated by p53 in Breast Tumor Cells through a Mechanism Involving an Intronic p53-binding Site
de Almodóvar, C. R., Ruiz‐Ruiz, C., Rodrı́guez, A., Ortiz-Ferrón, G., Redondo, J. M., & López‐Rivas, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311243200 · Cited by 48
Breathing new insights into the role of mutant p53 in lung cancer
Chen, T., Ashwood, L. M., Kondrashova, O., Strasser, A., Kelly, G. L., & Sutherland, K. D. (2024) · Oncogene · doi:10.1038/s41388-024-03219-6 · Cited by 49
Combined modality therapy with TRAIL or agonistic death receptor antibodies
Amm, H. M., Oliver, P. G., Lee, C. H., Li, Y., & Buchsbaum, D. J. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.5.14671 · Cited by 47
Halocynthiaxanthin and Peridinin Sensitize Colon Cancer Cell Lines to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand
Yoshida, T., Maoka, T., Das, S. K., Kanazawa, K., Horinaka, M., Wakada, M., Satomi, Y., Nishino, H., & Sakai, T. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0045 · Cited by 47
Insulin-like growth factor binding protein-2 is a novel mediator of p53 inhibition of insulin-like growth factor signaling
Grimberg, A., Coleman, C. M., Shi, Z., Burns, T. F., MacLachlan, T. K., Wang, W., & El‐Deiry, W. S. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.10.3455 · Cited by 44
Self-citation
A Novel Selective Progesterone Receptor Modulator Asoprisnil Activates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Signaling Pathway in Cultured Human Uterine Leiomyoma Cells in the Absence of Comparable Effects on Myometrial Cells
Sasaki, H., Ohara, N., Xu, Q., Wang, J., DeManno, D. A., Chwalisż, K., Yoshida, S., & Maruo, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0898 · Cited by 44
Proteasome inhibitor PS-341 (VELCADE) induces stabilization of the TRAIL receptor DR5 mRNA through the 3′-untranslated region
Kandasamy, K., & Kraft, A. S. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2368 · Cited by 43
Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer
Ferris, J., Espona‐Fiedler, M., Hamilton, C., Holohan, C., Crawford, N., McIntyre, A. J., Roberts, J. Z., Wappett, M., McDade, S. S., Longley, D. B., et al. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00296-w · Cited by 43
Comprehensive identification of genes driven by ERV9-LTRs reveals TNFRSF10B as a re-activatable mediator of testicular cancer cell death
Beyer, U., Krönung, S. K., Leha, A., Walter, L., & Dobbelstein, M. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.68 · Cited by 43
Piceatannol enhances TRAIL-induced apoptosis in human leukemia THP-1 cells through Sp1- and ERK-dependent DR5 up-regulation
Kang, C., Moon, D., Choi, Y. H., Choi, I., Moon, S., Kim, W., & Kim, G. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.12.006 · Cited by 43
CDIP, a novel pro‐apoptotic gene, regulates TNFα‐mediated apoptosis in a p53‐dependent manner
Brown, L. M., Ongusaha, P. P., Kim, H.-G., Nuti, S. L., Mandinova, A., Lee, J. W., Khosravi‐Far, R., Aaronson, S. A., & Lee, S. W. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601779 · Cited by 41
The Herbal Compound Cryptotanshinone Restores Sensitivity in Cancer Cells That Are Resistant to the Tumor Necrosis Factor-related Apoptosis-inducing Ligand
Tse, A. K., Chow, K.-Y., Cao, H., Cheng, C.-Y., Kwan, H. Y., Yu, H., Zhu, G., Wu, Y.-C., Fong, W. F., & Yu, Z. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.483909 · Cited by 40
Oncogenic Ras and B-Raf Proteins Positively Regulate Death Receptor 5 Expression through Co-activation of ERK and JNK Signaling
Oh, Y.-T., Yue, P., Zhou, W., Balko, J. M., Black, E. P., Owonikoko, T. K., Khuri, F. R., & Sun, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.304006 · Cited by 40
DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL‐mediated apoptosis via up‐regulation of TRAIL‐R2/DR5 and caspase‐8
Kurita, S., Higuchi, H., Saito, Y., Nakamoto, N., Takaishi, H., Tada, S., Saito, H., Gores, G. J., & Hibi, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01565.x · Cited by 40
Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines
Kouhara, J., Yoshida, T., Nakata, S., Horinaka, M., Wakada, M., Ueda, Y., Yamagishi, H., & Sakai, T. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.3.679 · Cited by 40
Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology
Pal, R., Srivastava, N., Chopra, R., Gochhait, S., Gupta, P., Prakash, N., Agarwal, G., & Bamezai, R. N. K. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-303 · Cited by 40
Fisetin Induces Apoptosis Through p53-Mediated Up-Regulation of DR5 Expression in Human Renal Carcinoma Caki Cells
Min, K., Nam, J., & Kwon, T. K. (2017) · Molecules · doi:10.3390/molecules22081285 · Cited by 40
A Novel Naphthyridine Derivative, 3u, Induces Necroptosis at Low Concentrations and Apoptosis at High Concentrations in Human Melanoma A375 Cells
Kong, Q., Lv, J., Yan, S., Chang, K., & Wang, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102975 · Cited by 39
Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP
Zhang, T., Wang, X., He, D., Jin, X., & Guo, P. (2014) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000116 · Cited by 39
Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma
Arts, H., de Jong, S., Hollema, H., ten Hoor, K. A., van der Zee, A. G. J., & de Vries, E. G. E. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.11.054 · Cited by 39
TRAIL pathway targeting therapeutics
Ralff, M. D., & El‐Deiry, W. S. (2018) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2018.1476062 · Cited by 38
Self-citation
Dying to Survive—The p53 Paradox
Lees, A., Sessler, T., & McDade, S. S. (2021) · Cancers · doi:10.3390/cancers13133257 · Cited by 38
Lethal and Non-Lethal Functions of Caspases in the DNA Damage Response
Lopez, K. E., & Bouchier‐Hayes, L. (2022) · Cells · doi:10.3390/cells11121887 · Cited by 38
Targeting Apoptosis Signaling Pathways for Anticancer Therapy
Fulda, S. (2011) · Frontiers in Oncology · doi:10.3389/fonc.2011.00023 · Cited by 38
Characterization of p53-mediated Up-regulation of CD95 Gene Expression upon Genotoxic Treatment in Human Breast Tumor Cells
Ruiz‐Ruiz, C., Robledo, G., Cano, E., Redondo, J. M., & López‐Rivas, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304397200 · Cited by 37
Expression of TRAIL, DR4, and DR5 in Bladder Cancer: Correlation With Response to Adjuvant Therapy and Implications of Prognosis
Li, Y., Jin, X., Li, J., Jin, X., Yu, J., Sun, X., Chu, Y., Xu, C., Li, X., Wang, X., et al. (2012) · Urology · doi:10.1016/j.urology.2011.11.011 · Cited by 37
Influence of TRP53 Status on FAS Membrane Localization, CFLAR (c-FLIP) Ubiquitinylation, and Sensitivity of GC-2spd (ts) Cells to Undergo FAS-Mediated Apoptosis1
Chandrasekaran, Y., McKee, C. M., Ye, Y., & Richburg, J. H. (2005) · Biology of Reproduction · doi:10.1095/biolreprod.105.045146 · Cited by 37
BNIP3 acts as transcriptional repressor of death receptor-5 expression and prevents TRAIL-induced cell death in gliomas
Burton, T. R., Henson, E. S., Azad, M. B., Brown, M., Eisenstat, D. D., & Gibson, S. B. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.100 · Cited by 36
Mutation analysis and mRNA expression of trail‐receptors in human breast cancer
Seitz, S., Wassmuth, P., Fischer, J., Nothnagel, A., Jandrig, B., Schlag, P. M., & Scherneck, S. (2002) · International Journal of Cancer · doi:10.1002/ijc.10694 · Cited by 36
The metabolism of cells regulates their sensitivity to NK cells depending on p53 status
Belkahla, S., Marco-Brualla, J., de Maudave, A. F., Falvo, P., Allende-Vega, N., Constantinides, M., Khan, A. U. H., Coënon, L., Alexia, C., Mitola, G., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07281-6 · Cited by 35
6-Dehydrogingerdione Sensitizes Human Hepatoblastoma Hep G2 Cells to TRAIL-Induced Apoptosis via Reactive Oxygen Species-Mediated Increase of DR5
Chen, C., Tai, C.-J., Cheng, J., Zheng, J.-J., Chen, Y.-Z., Liu, T., Yiin, S.-J., & Chern, C. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf904260b · Cited by 34
A novel response element confers p63- and p73-specific activation of the WNT4 promoter
Osada, M., Park, H. L., Nagakawa, Y., Begum, S., Yamashita, K., Wu, G., Kim, M. S., Trink, B., & Sidransky, D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.118 · Cited by 34
Modulation of TRAIL Signaling for Cancer Therapy
Fulda, S., & Debatin, K. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)67015-4 · Cited by 34
Elucidation for modulation of death receptor (DR) 5 to strengthen apoptotic signals in cancer cells
Min, K., Woo, S. M., Shahriyar, S. A., & Kwon, T. K. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-018-01103-y · Cited by 33
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis
Ohtsuki, T., Kikuchi, H., Koyano, T., Kowithayakorn, T., Sakai, T., & Ishibashi, M. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.07.041 · Cited by 33
Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model
White, C., Moesker, B., Beliakova‐Bethell, N., Martins, L. J., Spina, C. A., Margolis, D. M., Richman, D. D., Planelles, V., Bosque, A., & Woelk, C. H. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1006026 · Cited by 33
Tetrandrine (TET) Induces Death Receptors Apo Trail R1 (DR4) and Apo Trail R2 (DR5) and Sensitizes Prostate Cancer Cells to TRAIL-Induced Apoptosis
Shishodia, G., Koul, S., Dong, Q., & Koul, H. K. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1157 · Cited by 33
Chemopreventive agent-induced modulation of death receptors
Sun, S. (2005) · APOPTOSIS · doi:10.1007/s10495-005-2274-4 · Cited by 33
Suberoylanilide hydroxamic acid sensitizes human oral cancer cells to TRAIL-induced apoptosis through increase DR5 expression
Yeh, C., Deng, Y., Sha, D.-Y., Hsiao, M., & Kuo, M. Y. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0211 · Cited by 32
Ursolic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis
Shin, S., & Park, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.12.005 · Cited by 32
Triptolide sensitizes TRAIL-induced apoptosis in prostate cancer cells via p53-mediated DR5 up-regulation
Xiaowen, H., & Sun, Y. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1737-2 · Cited by 32
The p53 Protein Influences the Sensitivity of Testicular Germ Cells to Mono-(2-Ethylhexyl) Phthalate-Induced Apoptosis by Increasing the Membrane Levels of Fas and DR5 and Decreasing the Intracellular Amount of c-FLIP1
Chandrasekaran, Y., & Richburg, J. H. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.104.030858 · Cited by 32
p53-Independent up-regulation of a TRAIL receptor DR5 by proteasome inhibitors: A mechanism for proteasome inhibitor-enhanced TRAIL-induced apoptosis
Seol, D. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.053 · Cited by 31
New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma
Kozanoğlu, İ., Yandım, M. K., Çinçin, Z. B., Özdoğu, H., Çakmakoğlu, B., & Baran, Y. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1331-y · Cited by 31
Characterization of distinct consecutive phases in non-genotoxic p53-induced apoptosis of Ewing tumor cells and the rate-limiting role of caspase 8
Kovar, H., Jug, G., Printz, D., Bartl, S., Schmid, G., & Węsierska‐Gądek, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203780 · Cited by 31
Activation of stress-responsive promoters by ionizing radiation for deployment in targeted gene therapy
Chastel, C., Jiricny, J., & Jaussi, R. (2004) · DNA repair · doi:10.1016/j.dnarep.2003.12.002 · Cited by 30
Selection for TRAIL resistance results in melanoma cells with high proliferative potential
Wu, J., Zhang, X. D., Gillespie, S., & Hersey, P. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.041 · Cited by 30
Retracted
Salinomycin inhibits epigenetic modulator EZH2 to enhance death receptors in colon cancer stem cells
Singh, A. K., Verma, A., Singh, A., Arya, R. K., Maheshwari, S., Chaturvedi, P., Nengroo, M. A., Saini, K. K., Vishwakarma, A. L., Singh, K., et al. (2020) · Epigenetics · doi:10.1080/15592294.2020.1789270 · Cited by 29
Adenovirus-mediated p53 tumor suppressor gene therapy of osteosarcoma
Ternovoi, V. V., Curiel, D. T., Smith, B. F., & Siegal, G. P. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700444 · Cited by 29
Sequential Treatment by Ionizing Radiation and Sodium Arsenite Dramatically Accelerates TRAIL-Mediated Apoptosis of Human Melanoma Cells
Ivanov, V. N., Zhou, H., & Hei, T. K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0551 · Cited by 29
Targeting Pro-Apoptotic TRAIL Receptors Sensitizes HeLa Cervical Cancer Cells to Irradiation-Induced Apoptosis
Maduro, J. H., de Vries, E. G. E., Meersma, G.-J., Hougardy, B. M. T., van der Zee, A. G. J., & de Jong, S. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.06.1902 · Cited by 29
Mitochondrial inhibitor sensitizes non-small-cell lung carcinoma cells to TRAIL-induced apoptosis by reactive oxygen species and Bcl-XL/p53-mediated amplification mechanisms
Shi, Y.-L., Feng, S., Chen, W., Hua, Z.-C., Bian, J.-J., & Yin, W. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.547 · Cited by 28
Functional implication of TRAIL −716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor
Pal, R., Gochhait, S., Chattopadhyay, S., Gupta, P., Prakash, N., Agarwal, G., Chaturvedi, A., Husain, N., Husain, S. A., & Bamezai, R. N. K. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0900-5 · Cited by 28
YIPF2 promotes chemotherapeutic agent-mediated apoptosis via enhancing TNFRSF10B recycling to plasma membrane in non-small cell lung cancer cells
Wang, Y., Guo, S., Li, D., Tang, Y., Li, L., Su, L., & Liu, X. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2436-x · Cited by 28

Authors: Takimoto, R., & El-Deiry, W. S.
Affiliations: Howard Hughes Medical Institute (US)
Venue: Oncogene
Publisher: Springer Science and Business Media LLC
Published: 2000-03-30
Volume: 19
Issue: 14
Pages: 1735-1743
ISSN: 0950-9232 (ISSN-L)
1476-5594
DOI: 10.1038/sj.onc.1203489
OpenAlex: W2053301688
Cited by: 360
References: 39
Citations by year: 2026: 3 · 2025: 6 · 2024: 3 · 2023: 12 · 2022: 5 · 2021: 6 · 2020: 11 · 2019: 10 · 2018: 7 · 2017: 10 · 2016: 8 · 2015: 10 · 2014: 12 · 2013: 8 · 2012: 18
FWCI: 7.78
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Oncogene (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
Japan Health Sciences Foundation
National Cancer Institute (P01CA075138, P01 CA75138-01)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords: p53, DR5, TRAIL, p53 target genes, intronic enhancer, transcriptional activation, doxorubicin, p53 stabilization, apoptosis, E6 oncoprotein
MeSH terms: Binding Sites, DNA, DNA Damage, Doxorubicin, Humans, Introns, Oncogene Proteins, Viral, Promoter Regions, Genetic, Tumor Cells, Cultured, Transcriptional Activation, Gene Expression, Tumor Suppressor Protein p53, Mutagenesis, Apoptosis, Genes, Reporter, Receptors, Tumor Necrosis Factor, Receptors, TNF-Related Apoptosis-Inducing Ligand

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks